Pain Assessment
19
6
7
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.3%
1 terminated out of 19 trials
88.9%
+2.4% vs benchmark
11%
2 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (19)
Determining the Relationship Between Posture, Muscle Stiffness, Pain, and Jaw Functionality in Individuals With Bruxism
Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment
Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment
The Effects of Drama Activities on Nursing Students' Attitudes Towards Pain Assessment
Dietary Wild Blueberries and Joint Health
Oxytocin for Hypermobile Ehlers-Danlos Syndrome
Training and Support Programme on Data-driven Quality Development for Swiss Long-Term Care Facilities (NIP-Q-UPGRADE Subaim 2.6)
Refining mUltiple Artificial intelliGence strateGies for Automatic Pain Assessment Investigations: RUGGI Study
The Efficacy of Scalp Block in Craniotomy
Effect of Starpen CCLAD in Injection and Extraction
Implementing Music Therapy for Video-Assisted Thoracoscopic Surgery Patients: A Quality Improvement Initiative
ASSESSMENT OF PAIN USING A PAIN DIAGNOSTIC SYSTEM THAT MEASURS FACIAL MOVEMENT USING
Intraoperative Analgesia Based on ANI
Post-operative Pain With Different Apical Finishing Sizes After Single Visit Root Canal Treatment
Establishment and Validation of Early-warning Model of Perioperative Pain for the Elders
Pain Index Extracted From EEG in Monitoring Chronic Pain
Validation of the Bernese Pain Scale for Neonates
A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery
A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.